Related Articles
Aberrant hypomethylation-mediated CD147 overexpression promotes aggressive tumor progression in human prostate cancer
CD147 promotes epithelial‑mesenchymal transition of prostate cancer cells via the Wnt/β‑catenin pathway
miR‑505 suppresses prostate cancer progression by targeting NRCAM Corrigendum in /10.3892/or.2020.7696
TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR‑155
CD147 modulates androgen receptor activity through the Akt/Gsk-3β/β-catenin/AR pathway in prostate cancer cells